Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$9,027,585
+$1,704,915 QoQ
Shares Held
35,875
+6.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#976
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$251,640
PutShares
1,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Soltis Investment Advisors LLC holds $50,374,735 across 12 Drug Manufacturers - General names. ABBV ranks #3 (17.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
49,990 | $12,695,960 | |
| 2 | AMGN |
Amgen Inc
|
29,172 | $10,563,764 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
35,875 | $9,027,585 | |
| 4 | LLY |
ELI LILLY & Co
|
5,809 | $6,967,489 | |
| 5 | MRK |
Merck & Co., Inc.
|
48,517 | $6,234,434 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
42,594 | $2,454,266 | |
| 7 | PFE |
Pfizer Inc
|
26,981 | $649,702 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,981 | $629,299 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $251,640 | 1,000 | Put | Sole | 2026-07-31 | |
| 2026-06-30 | $9,027,585 | 35,875 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $7,322,670 | 33,669 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $7,786,253 | 34,077 | Shares | Sole | 2026-04-02 | |
| 2025-09-30 | $5,089,480 | 21,981 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,131,529 | 22,258 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $4,263,312 | 20,348 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,667,017 | 20,636 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $9,372,005 | 47,458 | Shares | Sole | 2025-01-03 | |
| 2024-06-30 | $8,271,208 | 48,223 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,564,425 | 19,574 | Shares | Sole | 2024-05-29 | |
| 2023-12-31 | $3,033,227 | 19,573 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $3,030,389 | 20,330 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,666,306 | 19,790 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,116,799 | 19,557 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $2,937,100 | 18,174 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,387,864 | 17,792 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,698,832 | 17,621 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,709,182 | 16,712 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $2,238,297 | 16,531 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $1,784,061 | 16,539 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,844,705 | 16,377 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $1,772,968 | 16,383 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,750,080 | 16,333 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,441,293 | 16,455 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $218,254 | 2,223 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||